Tactical Medicine News Blog

The Chinese navy hospital ship Peace Ark / Hospital ship 866 (Daishando). VIDEO Ver video en Facebook  https://www.facebook.com/DrRamonReyesMD/videos/583078172035116 This is the Military Health System (Sistema de Emergencias del Ejercito de EUA) by Miliatary Health Peace Ark is the first hospital ship in the world with a 10,000-tonne capacity. China independently developed and built it. It has 8 decks;...

Managing epistaxis is often challenging, time-consuming, and takes practice. Even under the best circumstances, epistaxis often results in return visits for rebleeding and poor outcomes. Rarely should you do “nothing” for adults who present to the ED with or following epistaxis. If it produced enough blood to seek care (even without hemodynamic compromise), epistaxis [+] The post 11 Tips to Improve Epistaxis Management in the Emergency Department appeared first on ALiEM.

Radiation is commonly employed in hospitals around the world to treat tumors, typically using gamma ray beams of high energy photons, with a relatively long range, that penetrate all the tissues on the way to and from the tumor. This leads to substantial damage to healthy tissues and too often results in poor outcomes. An […]

Background: Historically, we have treated acute coronary syndrome with supplemental oxygen regardless of the patient’s oxygen saturation.  This intervention was based on the belief that pushing the patient’s PaO2 to supra therapeutic levels would increase O2 delivery to ischemic myocardium and help reduce myocardial injury.  More recent evidence, however, demonstrates that too much oxygen could be harmful (AVOID Trial) by causing coronary vasoconstriction and increasing oxidative stress. The DETO2X-AMI trial (Link is HERE) was a randomized trial of patients with suspected acute myocardial infarction and showed no difference in one year mortality in patients given 12 hours of high flow O2 compared with limited O2. Based on recent studies, current guidelines recommend that O2 should not be given to non-hypoxemic patients with STEMI or NSTEMI [2,3].

Scientists at the University of Massachusetts Amherst have developed a biosensor that is based on protein nanowires that are created by bacteria. The protein nanowires are highly sensitive to ammonia, in this case, which is present in the breath of patients with kidney disease, but it is likely possible to create nanowires for a huge […]